The role of fPSA, [-2]proPSA and the Prostate Health Index for the early prediction of outcome in patients with metastatic castration resistant prostate cancer on therapy with abirateroneacetate.

Schlack K, Krabbe LM, Eminaga O, Semjonow A, Boegemann M